# Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN

> **NCT03880396** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 62 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck

## Interventions

- **RADIATION:** hypofractionated Rth with platinol

## Key facts

- **NCT ID:** NCT03880396
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-10
- **Primary completion:** 2020-12-26
- **Final completion:** 2020-12-26
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03880396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03880396, "Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03880396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*